These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23400746)

  • 41. Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.
    Svoboda M; Wlcek K; Taferner B; Hering S; Stieger B; Tong D; Zeillinger R; Thalhammer T; Jäger W
    Biomed Pharmacother; 2011 Sep; 65(6):417-26. PubMed ID: 21719246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.
    Schneck DW; Birmingham BK; Zalikowski JA; Mitchell PD; Wang Y; Martin PD; Lasseter KC; Brown CD; Windass AS; Raza A
    Clin Pharmacol Ther; 2004 May; 75(5):455-63. PubMed ID: 15116058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic-pharmacodynamic model of fimasartan applied to predict the influence of a high fat diet on its blood pressure-lowering effect in healthy subjects.
    Lee J; Han S; Jeon S; Hong T; Yim DS
    Eur J Clin Pharmacol; 2013 Jan; 69(1):11-20. PubMed ID: 22660441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiatherosclerotic effects of the novel angiotensin receptor antagonist Fimasartan on plaque progression and stability in a rabbit model: a double-blind placebo-controlled trial.
    Lee JY; Lee CW; Kim WJ; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Son WC; Jung S; Park SW; Park SJ
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):229-36. PubMed ID: 23615162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers.
    Liu Y; Zhou S; Wan Y; Wu A; Palmisano M
    Br J Clin Pharmacol; 2014 Nov; 78(5):1050-7. PubMed ID: 24962564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
    Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Rifampin, a potent inducer of drug-metabolizing enzymes and an inhibitor of OATP1B1/3 transport, on the single dose pharmacokinetics of anacetrapib.
    Anderson MS; Cote J; Liu Y; Stypinski D; Auger P; Hohnstein A; Rasmussen S; Johnson-Levonas AO; Gutstein DE
    J Clin Pharmacol; 2013 Jul; 53(7):746-52. PubMed ID: 23670789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.
    Tian L; Liu H; Xie S; Jiang J; Han L; Huang Y; Li Y
    Clin Ther; 2011 May; 33(5):655-63. PubMed ID: 21665049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice.
    Kim JH; Lim IR; Joo HJ; Park CY; Choi SC; Jeong HS; Hong SJ
    Mol Med; 2019 Jul; 25(1):33. PubMed ID: 31307370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus.
    Stroh M; Palcza J; McCrea J; Marsilio S; Breidinger S; Panebianco D; Johnson-Levonas A; Kraft WK; Orford K; Murphy G; Agrawal N; Trucksis M; Wagner JA; Iwamoto M
    Cancer Chemother Pharmacol; 2012 May; 69(5):1247-53. PubMed ID: 22290273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3.
    Martinez-Becerra P; Briz O; Romero MR; Macias RI; Perez MJ; Sancho-Mateo C; Lostao MP; Fernandez-Abalos JM; Marin JJ
    Mol Pharmacol; 2011 Mar; 79(3):596-607. PubMed ID: 21173039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions.
    Shitara Y
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):220-7. PubMed ID: 21297316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studies.
    Tutunji LF; Tutunji MF; Alzoubi MI; Khabbas MH; Arida AI
    J Pharm Biomed Anal; 2010 Mar; 51(4):985-90. PubMed ID: 20004542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of ketoconazole on lobeglitazone pharmacokinetics in Korean volunteers.
    Sil Oh E; Ok Kim C; Kim KH; Kim YN; Kim C; Lee JI; Park MS
    Clin Ther; 2014 Jul; 36(7):1064-71. PubMed ID: 25047497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Placental transfer and mammary excretion of a novel angiotensin receptor blocker fimasartan in rats.
    Kim TH; Kim MG; Shin S; Chi YH; Paik SH; Lee JH; Yoo SD; Youn YS; Bulitta JB; Joo SH; Jeong SW; Weon KY; Shin BS
    BMC Pharmacol Toxicol; 2016 Jul; 17(1):35. PubMed ID: 27459959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of gemfibrozil, rifampicin, or probenecid on the pharmacokinetics of the SGLT2 inhibitor empagliflozin in healthy volunteers.
    Macha S; Koenen R; Sennewald R; Schöne K; Hummel N; Riedmaier S; Woerle HJ; Salsali A; Broedl UC
    Clin Ther; 2014 Feb; 36(2):280-90.e1. PubMed ID: 24491572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction Potentials.
    Rhee SJ; Lee HA; Lee S; Kim E; Jeon I; Song IS; Yu KS
    Pharm Res; 2018 Oct; 35(12):236. PubMed ID: 30324316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15.
    Deng JW; Song IS; Shin HJ; Yeo CW; Cho DY; Shon JH; Shin JG
    Pharmacogenet Genomics; 2008 May; 18(5):424-33. PubMed ID: 18408565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.